Search results
Results From The WOW.Com Content Network
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer ; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer .
The investment firm she heads, Ark Invest, holds over 330,000 shares of Exact Sciences. She isn't the only one who isn't giving up on the company. Analysts on Wall Street have set an average price ...
This may seem like a low number, but at an average price tag of $2,536 -- and a gross profit of more than $1,500 per test -- it adds up. It generated $563 million in revenue in 2023. Guardant ...
Weather. Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript. Motley Fool Transcribing, The Motley Fool. August 1, 2024 at 12:00 AM. Logo of jester cap with thought bubble. Image source: The ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Exact Sciences (EXAS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
exactEarth Ltd is a Canadian company that specializes in data services that deliver real-time global location-based maritime vessel tracking information utilizing patented satellite AIS detection technology. exactEarth provides satellite AIS data services to commercial markets as well as government customers in India, Canada, United States ...
The stock of Exact Sciences (NAS:EXAS, 30-year Financials) appears to be significantly undervalued, according to GuruFocus Value calculation.